Research on BC has identified distinct molecular subtypes and therapeutically important biomarkers such as human epidermal growth factor receptor-2 (HER2), estrogen receptor-alpha (ERα) and progesterone receptor (PR) [2]. This evidence concerns the gene ESR1 and breast cancer.